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Background
Meta-analysis based on individual participant data (IPD)
is widely accepted as the most reliable approach and has
been described as the ‘gold standard‘ for systematic
reviews. An IPD approach often allows more powerful,
consistent and thorough analyses but does require addi-
tional resources compared with meta-analyses based on
aggregate data (AD). Several empirical comparisons of
IPD with AD meta-analyses have been published, some
of which show that IPD meta-analyses can differ in
important ways from meta-analyses based on AD. For
example, the importance of including as much follow-up
as possible on all randomised participants and data from
all relevant trials was shown in separate empirical com-
parisons [1-3] whilst Duchateau [4] found substantial
differences between IPD and literature-based AD meta-
analyses, mainly due to different approaches to analysis.
An unpublished review [5] summarised results from
across 25 studies, showing that for two thirds of the
comparisons AD estimated effect sizes with less preci-
sion and tended to overestimate the IPD effect but dif-
ferences were small in most comparisons.
Objectives
We have undertaken a Cochrane systematic review of
empirical studies that compared IPD and AD meta-ana-
lysis to explore key reasons for the differences.
Methods
The Cochrane Methodology Register, CENTRAL, MED-
LINE and EMBASE were searched using a predefined
set of search terms. Studies that report an empirical
comparison of IPD meta-analysis against AD meta-ana-
lysis of randomised trials were assessed for inclusion, by
two reviewers independently. Data were extracted by
two reviewers independently and stored in a central
database.
Results
Over forty empirical studies have satisfied the inclusion
criteria for this review. Estimates of effect size and pre-
cision obtained from IPD and AD will be compared and
differences will be discussed. Results will help inform
the ongoing debate about whether, and when IPD may
be most valuable.
Author details
1North West Hub for Trials Methodology Research, University of Liverpool,
UK.
2Department of Medicine, University of Perugia, Perugia, Italy.
3Departments of Epidemiology, Biostatistics & HTA and Operating Rooms,
UMC St Radboud, The Netherlands.
4Department of Clinical Epidemiology
and Biostatistics, McMaster University, Hamilton, ON, Canada.
5Public Health,
Epidemiology and Biostatistics, University of Birmingham, UK.
6All-Ireland
Hub for Trials Methodology Research, Queen’s University Belfast, UK.
Published: 13 December 2011
References
1. Stewart LA, Parmar MKB: Meta-analysis of the literature or of individual
patient data: is there a difference? Lancet 1993, 341:418-22.
2. Clarke M, Stewart L: Individual patient data or published meta-analysis: a
systematic review. Second International Conference Scientific Basis of Health
Services & Fifth Annual Cochrane Colloquium 1997, a94.
3. Williamson PR, Marson AG, Tudur C, Hutton JL, Chadwick DW: Individual
patient data meta-analysis of randomized anti-epileptic drug
monotherapy trials. Journal of Evaluation in Clinical Practice 2000, 6:205-14.
4. Moniem Mukhtar A: Incorporation of heterogeneity in meta-analysis of
randomised controlled trials. PhD thesis 2008.
5. Duchateau L, Pignon JP, Bijnens L, Bertin S, Bourhis J, Sylvester R: Individual
patient- versus literature-based meta-analysis of survival data: time to
1North West Hub for Trials Methodology Research, University of Liverpool,
UK
Full list of author information is available at the end of the article
Smith et al. Trials 2011, 12(Suppl 1):A57
http://www.trialsjournal.com/content/12/S1/A57 TRIALS
© 2011 Smith et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.event and event rate at a particular time can make a difference, an
example based on head and neck cancer. Controlled Clinical Trials 2001,
22:538-547.
doi:10.1186/1745-6215-12-S1-A57
Cite this article as: Smith et al.: Individual participant data meta-
analyses compared with meta-analyses based on aggregate data. Trials
2011 12(Suppl 1):A57.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Smith et al. Trials 2011, 12(Suppl 1):A57
http://www.trialsjournal.com/content/12/S1/A57
Page 2 of 2